321 results
Page 3 of 17
8-K
EX-1.1
5w5xfcgspddl8xflh7p
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
8-K
EX-4.1
xkv291eina 1di
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
8-K
EX-4.2
5fvukqqhx romgnbot
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
S-8
EX-4.4
l7t59gdz0db8 zl
12 Feb 21
Registration of securities for employees
4:23pm
8-K
EX-10.1
n70jmtk5mk qf
31 Dec 20
Departure of Directors or Certain Officers
4:16pm
DEF 14C
996ee
29 Dec 20
Information statement
4:59pm
8-K
EX-10.1
7e55dv7208ic
23 Jul 20
Departure of Directors or Certain Officers
4:55pm
8-K
EX-4.1
a2s4sk6wjdfz1
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
8-K
EX-4.2
yuhv4
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
424B4
x8xzo8s0
21 May 20
Prospectus supplement with pricing info
6:04am
8-K
EX-99.1
5vusvx2lsr1k4f3v9 0a
14 May 20
Windtree Therapeutics Reports First Quarter 2020 Financial Results and Provides Key Business Updates
8:12am